21st EVF Scientific Programme

21st Virtual Meeting of the European Venous Forum

24-26 June 2021


Online Programme  |  Scientific Programme  | Scientific Programme & Book of Abstracts

All hours on timeline in BST 


18 European CME Credits (ECMECs)

The conference has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) for a maximum of 18 European CME credits (ECMEC®s). CME credits are awarded for attendance of the live presentations during the 3 days of the conference and for attendance of the recorded presentations viewed within three months of the event.

Individual delegates access to meeting rooms will be monitored to provide a certificate of attendance with a number of CME credits (1 CME credit per 1 hour of attendance).


Recordings will be available to all registered delegates for one year post conference



  • Abstract Session 1: (10 minute presentation, 10 minute discussion)
  • Venous Thromboembolism, Anticoagulation, Iliac Stenting, Villalta Scale
  • Chair: I Bihari (Hungary), A Nicolaides (Cyprus)
08.30       1.1
  • Comparison of thrombus regression between direct oral anticoagulants and warfarin in patients with deep vein thrombosis.
  • Hosoi Yutaka; Nunokawa Masao; Mochizuki Yasuaki; Ichikawa Yohei; Sasajima Hiroshi; Fujimaki Keisuke; Kubota, Hiroshi
  • Cardiovascular Surgery, Kyorin University, Tokyo, Japan
08.50       1.2
  • Gender-related hemorrhagic events during rivaroxaban therapy.
  • Dzhenina Olga; Bogachev Vadim
  • First Phlebological Centre, Moscow, Russia
09.10      1.3
  • Sulodexide may accelerate and promote deep vein thrombosis resolution
  • Aldrett Lee, Erasto1; Fratti Munari, Alberto2
  • 1Grupo de Atención Vascular Integral, San Luis Potosi, Mexico; 2Grupo de Atencion Vascular Integral, Mexico City, Mexico;
09.30       1.4
  • Risk factors and frequency of recurrent long-term venous thromboembolism after superficial vein thrombosis of the lower limbs.
  • Papageorgopoulou Chrysanthi P; Kakkos Stavros; Nikolakopoulos Konstantinos M; Ntouvas Ioannis; Papadoulas Spyros; Kouri Anastasia; Tsantrizos Polyzois
  • Vascular Surgery, University Hospital of Patras, Patras, Greece
09.50       1.5
  • Quality of life outcomes after iliac vein stenting for chronic deep venous obstruction: a tertiary centre experience using the VEINES-QoL/SYM.
  • Morris Rachael; Pouncey Anna; Khan Taha; Gwozdz, Adam; Quintana, Belen; Saha Prakash; Black Stephen
  • Academic Department of Vascular Surgery, School of Cardiovascular Medicine and Sciences, St Thomas’ Hospital, London, UK

Submitted for the EVF Prize

10.10       1.6
  • Assessment of the Villalta tool in a population with primary chronic venous disease.
  • Kemal Kemal; Onida Sarah; Davies Alun
  • Imperial College London, London, UK

Submitted for the EVF Prize

10.30-11.00 View ePoster Presentations and visit Virtual Exhibition
  • Abstract Session 2: (10 minute presentation, 10 minute discussion)
  • Thermal ablation, Cyanoacrylate, Sclerotherapy, Haemodynamics
  • Chair: D Heim (Switzerland), A Szabo (Hungary)
11.00      2.1
  • Randomised clinical trial of mechanochemical ablation versus cyanoacrylate adhesive for the treatment of varicose veins (MOCCA).
  • Belramman Amjad1; Lane Tristan R A1; Bootun Roshan1; Tang Tjun Yip2; Davies Alun H1
  • 1Imperial College London, London, London, UK; 2Singapore General Hospital and Sengkang General Hospital, Singapore., Singapore, Singapore

Submitted for the EVF Prize

11.20       2.2
  • Mid-term results of cyanoacrylate embolization for saphenous veins: efficacy, complications and their treatment.
  • Murzina Elena1; Lobastov Kirill2; Bargandzhiya Astanda2; Laberko Leonid2; Popov Ivan3
  • 1Hospital «Neftyanik», Tyumen, Russia; 2Pirogov Russian National Research Medical University, Moscow, Russia; 3Tyumen State Medical University, Tyumen, Russia
11.40       2.3
  • Mechanisms of damage to the venous wall and dissolving venaseal glue in an animal experiment.
  • Markin SM.1; Mazayshvili KV.2; Agalarov RM.2; Gustelev YuA.2; Gitsuk YaV.1; Mordovin, A.I.1
  • 1Federal State Budgetary Health Institution “St. Petersburg Clinical Hospital of the Russian Academy of Sciences, Saint-Petersburg, Russia; 2Department of Faculty Surgery, Surgical University, Surgut State University, Surgut, Russia

Submitted for the EVF Prize

12.00       2.4
  • Efficacy and safety of radiofrequency thermal ablation of great saphenous vein compared to saphenous-femoral junction ligature and stripping. A randomized exploratory study.
  • Reina-Gutierrez Lourdes1; Fernández-Solares Jose Ignacio1; Nowak-Tarnawska, Agnieszka1; Barrio-Rodriguez, Carlos1;Florez-Gonzalez, Aurora1;Laime-Alvarez, Ilsem1; Fernández-Pérez, Cristina2; Sanjuanbenito-Reina, Alfonso3
  • 1Vascular Department, Hospital Central de la Cruz Roja, Madrid, Spain; 2Epidemiology Unit, Hospital Clinico San Carlos, Madrid, Spain; 3Grade of Medicine, Autonoma University, Madrid, Spain
12.20       2.5 



  • The study of systemic hemodynamic disorders in patients with varicose veins and post-thrombotic syndrome.
  • Suchkov Igor; Kalinin Roman; Mzhavanadze Nina; Shanaev Ivan
  • Ryazan State Medical University, Ryazan, Russia

Submitted for the EVF Prize

12.40       2.6
  • Ultrasound-guided foam sclerotherapy on larges great saphenous veins (over 8 mm diameter) with 1% vs 2% vs 3% polidocanol: A randomised trial.
  • Amorim Cláudia; Virgini-Magalhães Carlos Eduardo; Bandeira Julia
  • Vascular and Endovascular Surgery, University Hospital Pedro Ernesto, Rio de Janeiro, Brazil

Submitted for the EVF Prize

13.00-14.00 View ePoster Presentations (4 minute presentations) – See separate page for programme
13.00-14.00 Visit Virtual Exhibition
14.00-15.00 Industry Session 1
  • Didactic Session 1 (10 minute presentation, 5 minute discussion)
  • Messages from New Guidelines, Laser Crossectomy
  • Chair: Marianne De Maeseneer (Belgium), F Zernovicky (Slovakia)
15.00 Highlights of Guidelines of DVT management. Stavros Kakkos (Greece)
15.15 Laser ablation, radiofrequency ablation, surgery and ultrasound guided foam sclerotherapy: what do the new guidelines say and how do we apply it in practice? A Giannoukas (Greece)
15.30 Compression: Messages from the International Guidelines. G Szolnoky (Hungary)
15.45 Laser crossectomy. Twelve years and 2,300 cases. I Bihari (Hungary)
16.00-16.30 View ePoster Presentations  |  Visit Virtual Exhibition
  • Didactic Session 2 (10 minute presentation, 10 minute discussion)
  • Advanced CVD, MOCA, Cyanoacrylate, New devices
  • Chair: Alun Davies (UK), G Szolnoky (Hungary)
16.30 Endovenous procedures in patients with venous ulcers. G Menyhei (Hungary)
16.50 Cost-benefit of venous stenting. C Rognoni (Italy)
17.10 Venous insufficiency, barrier function of the microbiome and ulcer development. J Daróczy (Hungary)
17.30 MOCA: is it here to stay? A Szabó (Hungary)
17.50 Cyanoacrylate: Efficacy and Risks. T Proebstle (Germany)
18.10 Outlook into the future of VV therapy and the promise of new devices for telangiectasia. Dominik Heim (Switzerland)





  • Abstract Session 3: (10 minute presentation, 10 minute discussion)
  • Miscellaneous
  • Chair: Mark Malouf (Australia), Armando Mansilha (Portugal)
08.30       3.1
  • The evolution of venous symptoms after interventional treatment for varicose veins.
  • Lobastov Kirill; Bargandzhiya Astanda; Laberko Leonid; Dvornikov Anton
  • Pirogov Russian National Research Medical University, Moscow, Russia
08.50       3.2
  • V-move 2 v-care project: veines-QOL questionnaire was a valuable tool in assessing quality of life for patients presenting with venous ulcer in India over a 2 year period.
  • Jindal Ravul1; Gupta P2; Dekiwadia Devendra3
  • 1Fortis Hospital, Mohali, India; 2Private, Mumbai, India; 3Dekiwadia Hospital, Rajkot, India
09.10       3.3
  • Evaluation of microvalve alteration and assessment of MPFF treatment in an experimental model of venous hypertension.
  • Bouskela, Eliete1; Garcia de Almeida Cyrino, Fatima Zely1; Blanc-Guillemaud, Vanessa2
  • Cardiovascular and Metabolic Diseases Center for Therapeutic Innovation; Lucien, Arnaud2; Cardiovascular and Metabolic Diseases Center for Therapeutic InnLaboratory for Clinical and Experimental Research on Vascular Biology, Biomedical Center, State University of Rio de Janeiro, Rio de Janeiro, Brazil; 2Institut de Recherches Internationales Servier (I.R.I.S.), Suresnes Cedex, France
09.30       3.4
  • The impact of lower body compression garment on left ventricular rotational mechanics in patients with secondary leg lymphedema and lipedema.
  • Szolnoky, Gyozo1; Kormányos, Árpád2; Domsik, Péter2; Kalapos, Anita2; Kemény, Lajos1; Forster, Tamás2; Nemes, Attila2;
  • 1Department of Dermatology and Allergology; 22nd Department of Medicine and Cardiology Centre, University of Szeged, Szeged, Hungary
09.50       3.5
  • Factors, which are secreted by the venous endothelium upon exposure to oscillatory shear stress, affect adjacent cell layers of the vein wall.
  • Smetanina Mariia1; Shirshova Arina2; Zolotukhin Igor3; Shevela Andrey1 Filipenko Maxim1;
  • 1Laboratory of Pharmacogenomics, Institute of Chemical Biology and Fundamental Medicine (ICBFM); Novosibirsk State University (NSU), Novosibirsk, Russia; 2Institute of Chemical Biology and Fundamental Medicine (ICBFM), Novosibirsk, Russia; 3Faculty of Surgery, Medical Department, Pirogov Russian National Research Medical University (RNRMU); Institute of Chemical Biology and Fundamental Medicine (ICBFM), Moscow, Russia

Submitted for the EVF Prize

10.10       3.6
  • Could it be effective? Non-inferiority randomised trial of new type of compression stockings.
  • Demekhova, Marina1; Zolotukhin, Igor2; Ilyukhin, Evgeny1; Sonkin, Igor3; Zakharova, Elena2; Kiseleva, Ekaterina3; Efremova, Oksana2; Gavrilov, Evgenii4
  • 1Medalp clinic, Saint Petersburg, Russia; 2Pirogov Russian National Research Medical University, Moscow, Russia; 3Road Clinical Hospital of Russian Railways, Saint Petersburg, Russia; 4Military Medical Academy, Saint Petersburg, Russia

Submitted for the EVF Prize

10.30-11.00 View ePoster Presentations and visit Virtual Exhibition
11.00-12.00 Industry Session 2
  • EVF Invited Lecture
  • Chair: I Bihari (Hungary)
  • Introduction by Imre Bihari
12.00-13.00 The Best Vein Care is the Only Vein Care to be Considered. P Gloviczki (USA)
  • Didactic Session 3 (10 minute presentation, 5 minute discussion)
  • New Messages on VTE
  • Chair: Stavros Kakkos (Greece), Athanasios Giannoukas (Greece)
12.30-12.45 Efficacy of adjunctive IPC to standard prophylaxis of post-operative VTE in patients at extremely high risk. Kirill Lobastov (Russia)
12.45-13.00 COVID-19 and VTE. A Nicolaides (Cyprus)
13.00-14.00 View ePoster Presentations (4 minute presentations) – See separate page for programme
13.00-14.00 Visit Virtual Exhibition
14.00-15.00 EVF Annual General Meeting (Members Only)
  • Joint EVF/AVF Session (10 minute presentations, 5 minute discussion)
  • Current Controversies
  • Chair: Peter Gloviczky (USA), Z Pecsvarady (Hungary)
15.00 Iliac vein stenting for patients with the PTS. S Black (UK)
15.15 Thrombolysis in the prevention of PTS. N Baekgaard (Denmark)
15.30 How can infra-inguinal duplex be optimized to detect proximal iliac vein obstruction? Elna Masuda (USA)
15.45 Physician, Heal Thyself. Brajesh Lal (USA)
16.00-16.30 Visit ePoster Presentations  |  Visit Virtual Exhibition
16.30-17.30 Industry Session 3
  • Prize winning papers from the Japanese Society of Phlebology and American Venous Forum
  • (10 minute presentation, 5 minute discussion)
  • Chair: Bo Eklof (Sweden), Brajesh Lal (USA)
17.30-17.45  | Pr.1
  • Definite diagnosis of lymphedema using lymphatic echography.
  • Hisako Hara, Makoto Mihara
  • Department of Lymphatic and Reconstructive Surgery, JR Tokyo General Hospital, Tokyo, Japan
17.45-18.00  | Pr.2
  • Investigating a role for platelets in venous in-stent stenosis in patients with post-thrombotic syndrome
  • Gwozdz AM, 1Black SA, 1Morris R, 1Messiha S, 1Ikram M, 2Bye AP, 2Gibbins JM, 3Rand ML, 1Patel AS, 1Modarai BM, 1Smith A, 1Saha P.
  • 1Academic Department of Vascular Surgery, Section of Vascular Risk and Surgery, School of Cardiovascular Medicine and Science, St Thomas’ Hospital, King’s College London, UK, 2Institute for Cardiovascular and Metabolic Research, School of Biological Sciences, University of Reading, UK, 3Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, Canada
  • Awards Ceremony
  • Join us to find out the winners of the EVF Prizes and the EVF Poster Prize. Two Honorary Memberships of the EVF will also be announced



  • Abstract Session 4: (10 minute presentation, 10 minute discussion)
  • Sclerotherapy, laser, Glue
  • Chair: Jean-Jerome Guex (France), I Rozsos (Hungary)
08.30      4.1
  • The effect of the length and caliber of the needle on the stability of sclerosant foam.
  • Simka Marian; Hobot Jacek; Skuła Marcin
  • Department of Anatomy, University of Opole, Opole, Poland
08.50      4.2
  • Endovenous laser ablation (EVLT) with simultaneous sclerotherapy as a comprehensive approach to superficial venous pathology treatment.
  • Jaworucka- Kaczorowska Aleksandra
  • Center of Phlebology and Aesthetic Medicine, Gorzów Wlkp., Poland
09.10      4.3
  • Incidence of nerve injury after endovenous laser ablation for incompetent great saphenous veins.
  • Utoh Junichi1; Utoh Mei1; Tsukamoto, Yoshiharu2
  • 1Kumamoto Vascular Clinic, Kumamoto, Japan; 2Kikuchi Central Hospital, Kikuchi, Japan
09.30      4.4
  • Relevance of systematic vascular ultrasound evaluation post foam sclerotherapy procedures.
  • Heil Arostegui Pacheco Carolina; Arêas Marques Marcos; de Matos Milhomens Ana Leticia; Lascasas Porto Carmen Lucia; Santos Miller Cintia; de Oliveira Chimeli Luisa; Tiemi Kano Silva Aline; Souza de Oliveira Lais; de Miranda Vieira Juliana
  • State University of Rio de Janeiro, Rio de Janeiro, Brazil
09.50      4.5
  • Comparison of laser and glue in perforator vein treatment.
  • Bihari, Peter1; Ayoub, George1; Bihari, Imre2
  • 1A+B Clinic, Budapest, Hungary; 2A and B Clinic, Budapest, Hungary
10.10      4.6
  • Reducing hyperpigmentation after sclerotherapy (RHYAS) study: results of a multicenter, controlled, randomized clinical trial.
  • Gonzalez Ochoa, Alejandro1; Carrillo Joaquin2; Manriquez Diana2; Nuricumbo Alejandro3.
  • 1Hospital General Zona #12 Instituo Mexicano Seguro Social, San Luis Rio Colorado, Mexico; 2Vascular Surgery, Instituto Seguridad Social al Servicio de Trabajadores del Estado, Mexicali, Mexico; 3Vascular Surgery, Instituto Seguridad Social al Servicio de Trabajadores del Estado de Baja California, Mexicali, Mexico
10.30-11.00 View ePoster Presentations and visit Virtual Exhibition
  • Didactic Session 4. (10 minute presentation, 5 minute discussion)
  • Varicose vein recurrence, Compression, DOAC
  • Chair: Marzia Lugli (Italy), G Menyhei (Hungary)
11.00 A score system to predict varicose vein recurrence. I Bihari (Hungary)
11.15 Small saphenous vein treatment issues. F Zernovicky (Slovakia)
11.30 UEMS European Board of Phlebology. JJ Guex (France)
11.45 Phlebology training: instructions for trainers and trainees. O Maleti (Italy)
  • Abstract Session 5: 4 papers (10 minute presentation, 5 minute discussion)
  • Laser, Pathophysiology of CVD; Villalta Scale
  • Chairmen: Marianne Vandendriessche (Belgium), Eberhard Rabe (Germany)
12.00      5.1
  • Russian sulfacrylate glue (Venogluerus ). History, present and future.
  • E.V.Shaydakov 1, A.B.Sannikov, D.S. Sergeevichev3
  • 1PetroState University, Petrozavodsk, Saint-Petersburg, Russia, 2Medical Center “Palitra”, Vladimir, Russia, 3National medical research center for Circulation Pathology n. E.N. Meshalkin, Novosibirsk, Russia
12.15      5.2
  • Will padding the leg to a perfect circular shape give an even pressure during compression treatment?
  • Lundh Torbjörn1; Baaz, Marcus2; Nilsson Andreas3
  • 1Mathematical Sciences, Chalmers University of Technology and University of Gothenburg, Gothenburg, Sweden; 2University of Gothenburg, Gothenburg, Sweden; 3PressCise, Herrljunga, Sweden
12.30      5.3
  • Post-thrombotic syndrome in patients with double popliteal vein.
  • Minkova Boryana1; Dimitrov Svetoslav2; Daskalov Alexandar1; Vassil, Chervenkoff1;
  • 1Vascular Surgery, Acibadem City Clinic Tokuda Hospital, Sofia, Bulgaria; 2Vascular and Endovascular Surgery, Saint Ekaterina University Hospital, Sofia, Bulgaria
12.45      5.4
  • Mathematical modeling of the venous walls’ and valves’ deformations.
  • Goranova Elena1; Nikolov Nikola2;
  • 1Medical institute, Sofia, Bulgaria; 2 Fluids Mechanic Department, Bulgarian Academy of Sciences, Sofia, Bulgaria
  • Joint EVF/BVF Session (10 minute presentation, 5 minute discussion)
  • Chair: E Goranova (Bulgaria), A Giannoukas (Greece)
13.00 Update on the use of DOACs in cancer patients. Larisa Chernukha (Ukraine)
13.15 Haemodynamic assessment of outflow obstruction. Andrew Nicolaides (Cyprus)
13.30 Optimizing outcomes in acute DVT intervention. Efthymios Avgerinos (Greece & USA)
13.45 The ideal treatment of iliofemoral DVT. Mehmet Kurtoglu (Turkey)
14.00 Discussion
  • End of meeting
  • Winners of the Venous Masters Golf Scavenger Hunt and Winner Venous Exhibition Quiz will be announced
  • Presentation of 2022 Meeting



The views expressed in both oral and poster presentations at the meeting are the views of the author(s) of the presentation.  They are not necessarily the opinions and views of the European Venous Forum. Presentation at the meeting does not constitute an endorsement of the speaker’s views by EVF. The presence of a company at the virtual exhibition does not constitute the European Venous Forum’s endorsement of a product or company. Congress delegates are expected to use their own diligence and medical judgement for clinical application.

Comments are closed.